Roberto Cattaneo

Summary

Affiliation: University of Brescia
Country: Italy

Publications

  1. ncbi Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms
    Elisabetta Danieli
    Department of Rheumatology and Clinical Immunology, Spedali Civili, Piazzale Spedali Civili, 25124 Brescia, Italy
    Clin Rheumatol 24:48-54. 2005
  2. ncbi Anti beta2-glycoprotein I antibodies: clinical significance
    A Tincani
    Clinical Immunology Unit, Ospedale Civile di Brescia, Italy
    Lupus 7:S107-9. 1998
  3. ncbi Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients
    Franco Franceschini
    Clinical Immunology Unit, Spedali Civili, University of Brescia, Italy
    J Rheumatol 29:1393-7. 2002
  4. ncbi The immune development in a child born to a cyclosporin A-treated woman with systemic lupus erythematosus/polymyositis
    P Airo
    Division of Rheumatology and Clinical Immunology, Spedali Civili, Brescia, Italy
    Lupus 11:454-7. 2002
  5. ncbi Oesophageal manometry in early and definite systemic sclerosis
    Paolo Airo
    The Rheumatology, Allergology and Clinical Immunology Service, Spedali Civili and University, Brescia, Italy
    Clin Rheumatol 24:370-6. 2005
  6. doi Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma
    Angela Ceribelli
    Rheumatology Unit, A O Spedali Civili, Universita degli Studi, Brescia, Italy
    J Rheumatol 37:2071-5. 2010
  7. ncbi Upregulation of myxovirus-resistance protein A: a possible marker of type I interferon induction in systemic sclerosis
    Paolo Airo
    Rheumatology and Clinical Immunology Service, Spedali Civili di Brescia, Brescia, Italy
    J Rheumatol 35:2192-200. 2008
  8. ncbi Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide
    Frédéric A Houssiau
    Cliniques Universitaires St Luc, Universite Catholique de Louvain, Brussels, Belgium
    Arthritis Rheum 46:2121-31. 2002
  9. ncbi Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial
    Frédéric A Houssiau
    Universite Catholique de Louvain, Brussels, Belgium
    Arthritis Rheum 50:3934-40. 2004
  10. pmc Measles virus V protein inhibits p53 family member p73
    Cristian D Cruz
    Pancoe ENH Research Pavilion, Northwestern University, 2200 Campus Drive, Evanston, IL 60208, USA
    J Virol 80:5644-50. 2006

Collaborators

Detail Information

Publications11

  1. ncbi Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms
    Elisabetta Danieli
    Department of Rheumatology and Clinical Immunology, Spedali Civili, Piazzale Spedali Civili, 25124 Brescia, Italy
    Clin Rheumatol 24:48-54. 2005
    ..A strong correlation with disability and with depressive symptoms was observed. In conclusion, patients with SSc perceived a reduced HR-QOL similar to that of patients with RA. SF-36 may provide useful information in their evaluation...
  2. ncbi Anti beta2-glycoprotein I antibodies: clinical significance
    A Tincani
    Clinical Immunology Unit, Ospedale Civile di Brescia, Italy
    Lupus 7:S107-9. 1998
    ..This observation suggests that anti beta2GPI may also modify the immunogenicity of apoptotic bodies and of the autoantigens that they contain...
  3. ncbi Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients
    Franco Franceschini
    Clinical Immunology Unit, Spedali Civili, University of Brescia, Italy
    J Rheumatol 29:1393-7. 2002
    ..To assess the clinical and serological associations of anti-Ku antibodies...
  4. ncbi The immune development in a child born to a cyclosporin A-treated woman with systemic lupus erythematosus/polymyositis
    P Airo
    Division of Rheumatology and Clinical Immunology, Spedali Civili, Brescia, Italy
    Lupus 11:454-7. 2002
    ..Lymphocyte phenotypical and functional studies, as well as response to vaccination, were also normal...
  5. ncbi Oesophageal manometry in early and definite systemic sclerosis
    Paolo Airo
    The Rheumatology, Allergology and Clinical Immunology Service, Spedali Civili and University, Brescia, Italy
    Clin Rheumatol 24:370-6. 2005
    ..The correlation between LES abnormalities and FVC suggests a possible causal relationship between these disease manifestations...
  6. doi Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma
    Angela Ceribelli
    Rheumatology Unit, A O Spedali Civili, Universita degli Studi, Brescia, Italy
    J Rheumatol 37:2071-5. 2010
    ..We examined the autoantibody profiles and clinical manifestations in a cohort of Italian patients with SSc, focusing on anti-Th/To and anticentromere (ACA) antibodies, associated with limited cutaneous SSc (lcSSc)...
  7. ncbi Upregulation of myxovirus-resistance protein A: a possible marker of type I interferon induction in systemic sclerosis
    Paolo Airo
    Rheumatology and Clinical Immunology Service, Spedali Civili di Brescia, Brescia, Italy
    J Rheumatol 35:2192-200. 2008
    ....
  8. ncbi Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide
    Frédéric A Houssiau
    Cliniques Universitaires St Luc, Universite Catholique de Louvain, Brussels, Belgium
    Arthritis Rheum 46:2121-31. 2002
    ..Given the side effects of this regimen, we evaluated the efficacy and the toxicity of a course of low-dose IV CYC prescribed as a remission-inducing treatment, followed by azathioprine (AZA) as a remission-maintaining treatment...
  9. ncbi Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial
    Frédéric A Houssiau
    Universite Catholique de Louvain, Brussels, Belgium
    Arthritis Rheum 50:3934-40. 2004
    ..After a median followup of 41 months, a difference in efficacy between the 2 regimens was not observed. The present analysis was undertaken to extend the followup and to identify prognostic factors...
  10. pmc Measles virus V protein inhibits p53 family member p73
    Cristian D Cruz
    Pancoe ENH Research Pavilion, Northwestern University, 2200 Campus Drive, Evanston, IL 60208, USA
    J Virol 80:5644-50. 2006
    ..These findings also suggest that p73-PUMA signaling may be a previously unrecognized arm of cellular innate antiviral immunity...
  11. ncbi Intravenous immunoglobulin in pregnancy: a chance for patients with an autoimmune disease
    Angela Tincani
    Isr Med Assoc J 9:553-4. 2007